Evidence map›Paper›PMID 38130313›Full record

ArticleTranslational cancer research2023

A STEP ahead for CAR-T cell therapy of large B cell lymphoma: understanding the molecular determinants of resistance.

Samir Mouhssine, Nawar Maher, Gianluca Gaidano

Abstract readEditorialComment
In one paragraph

Article in Translational cancer research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Liquid Biopsy in B and T Cell Lymphomas: From Bench to Bedside.International journal of molecular sciences · 2025
    Review
  6. Review
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Samir MouhssineDivision of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.
Nawar MaherDivision of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.
Gianluca GaidanoDivision of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

axicabtagene ciloleucel (axi-cel)chimeric antigen receptor (CAR)-T cellsLarge B cell lymphoma (LBCL)simultaneous tumor and effector profilingtreatment resistance

Identifiers

PMID38130313
PMCPMC10731332

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.